• EN

Drug-related infectious diseases key (DRID) indicator



Drug-related infectious diseases key epidemiological indicator

Drug-related infectious diseases (DRID)

This key indicator collects data on the extent of infectious diseases — primarily HIV, hepatitis C and hepatitis B infection — among people who inject drugs (injecting drug users or IDUs). The data is collected from IDUs each calendar year using two main methods. These are: (a) surveys of IDUs that include serological testing and (b) the monitoring of routine diagnostic testing for HIV, hepatitis C and hepatitis B infection among IDUs.
Read more »

Key methodological documents

Overview of the DRID key indicator (9 pages, PDF)
This document provides an overview of the drug-related infectious diseases indicator. It is written in an easy to understand manner and is intended for a wider readership.

DRID statistical methods and definitions
Part of the EMCDDA Statistical bulletin, this text provides a summary of the methods and definitions used in DRID and is primarily intended to assist in the interpretation of data.

DRID toolkit (November 2013)

The most recent work in DRID has resulted in a more flexible approach to DRID guidance, through a toolkit with modules and is principally aimed at professionals in the field. The first three modules were finalised in 2013 and cover:

  • Behavioural indicators
    A contextual complement to biological monitoring, covering risk and protective behaviours, testing, service uptake etc.
  • Example questionnaire
    More detailed questions as applicable in national studies, including those that are needed to construct the behavioural indicators
  • Methods of bio-behavioural studies
    Provides a short overview of methods and issues with regard to setting up monitoring through repeated studies in people who inject drugs

Page last updated: Tuesday, 07 February 2017